Moleculin Biotech, Inc. Warrant Down Round Feature Increase Decrease In Equity Amount1
Moleculin Biotech, Inc. (MBRX) reported Warrant Down Round Feature Increase Decrease In Equity Amount1 of -$329.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Shareholders' Equity
us-gaap:WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount1 · last filed 2026-08-13
- Moleculin Biotech, Inc. warrant down round feature increase decrease in equity amount1 for the quarter ending 2026-06-30 was -$329.00K.
- Moleculin Biotech, Inc. warrant down round feature increase decrease in equity amount1 for the quarter ending 2026-03-31 was -$1.76M.
| Period end | Warrant Down Round Feature Increase Decrease In Equity Amount1 3 month | Warrant Down Round Feature Increase Decrease In Equity Amount1 6 month |
|---|---|---|
| 2026-06-30 | -$329.00K 10-Q · filed 2026-08-13 | -$2.09M derived: sum of 2 quarters · filed 2026-08-13 |
| 2026-03-31 | -$1.76M 10-Q · filed 2026-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |